Bio-Connect
IHC-P analysis of human tonsil tissue using GTX22356 ERCC1 antibody [8F1].
IHC-P analysis of human tonsil tissue using GTX22356 ERCC1 antibody [8F1].
IHC-P analysis of human tonsil tissue using GTX22356 ERCC1 antibody [8F1].

ERCC1 antibody [8F1]

GTX22356
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetERCC1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    ERCC1 antibody [8F1]
  • Delivery Days Customer
    9
  • Application Supplier Note
    IHC-P: 1:100-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    8F1
  • Conjugate
    Unconjugated
  • Gene ID2067
  • Target name
    ERCC1
  • Target description
    ERCC excision repair 1, endonuclease non-catalytic subunit
  • Target synonyms
    COFS4; DNA excision repair protein ERCC-1; excision repair cross-complementation group 1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence); RAD10; UV20
  • Host
    Mouse
  • Isotype
    IgG2b
  • Protein IDP07992
  • Protein Name
    DNA excision repair protein ERCC-1
  • Scientific Description
    The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5 incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin. Munoz-Montano W et al., 2021 Aug 5, BMC Cancer
    Read more
  • Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence. Wang YY et al., 2021 Jun, Oncol Lett
    Read more
  • Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray. Kim SH et al., 2019 Jun 19, Cancer Res Treat
    Read more
  • ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer. Han JY et al., 2017 Jul, Cancer Res Treat
    Read more
  • Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. Ahn JS et al., 2015 Aug 20, J Clin Oncol
    Read more
  • Immunohistochemical comparison of biomarker expression in biopsy and surgical specimens of non-small cell lung cancer. Okimoto T et al., 2014 Jun, Anticancer Res
    Read more
  • ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy. Sun JM et al., 2012 May 22, BMC Cancer
    Read more
  • In vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) in solid pseudopapillary tumor of the pancreas. Kang CM et al., 2012 Apr, Pancreas
    Read more
  • Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer. Yoon YK et al., 2012 Aug 28, Cancer Lett
    Read more
  • Prognostic significance of ERCC1 expression in resected non small cell lung carcinoma. Seyhan EC et al., 2011, Ann Thorac Cardiovasc Surg
    Read more